Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 2:7:30.
doi: 10.1186/s13098-015-0026-3. eCollection 2015.

IRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia

Rafael B Gelaleti  1 , Débora C Damasceno  1 , Daisy M F Salvadori  2 , João Paulo C Marcondes  2 , Paula H O Lima  1 , Glilciane Morceli  1 , Iracema M P Calderon  1 , Marilza V C Rudge  1
Affiliations

IRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia

Rafael B Gelaleti et al. Diabetol Metab Syndr. .

Abstract

Background: Pregnant women with mild gestational hyperglycemia present a high risk for hypertension and obesity, and appear to reproduce the model of metabolic syndrome in pregnancy, including hyperinsulinemia and insulin resistance. Diabetic patients have a higher frequency of the IRS-1 Gly972Arg variant and this polymorphism is directly related to insulin resistance and subsequent hyperglycemia. In diabetes, hyperglycemia and other associated factors generate reactive oxygen species that increase DNA damage. The aims of this study were to evaluate the presence of the IRS-1 Arg972 polymorphism in pregnant women with diabetes or mild gestational hyperglycemia, and in their newborns. Additionally, we evaluated the level of primary DNA damage in lymphocytes of Brazilian pregnant women and the relationship between the amount of genetic damage and presence of the polymorphism.

Methods: A based on the oral glucose tolerance test (OGTT) results and on glycemic profiles (GP), as follows: non-diabetic group, mild gestational hyperglycemia (MGH) and diabetic group. Eighty-five newborns were included in the study. Maternal peripheral blood samples and umbilical cord blood samples (5-10 mL) were collected for genotyping by PCR-RFLP and for comet assays.

Results: The prevalence of genotype Gly/Arg in pregnant women groups was not statistically significant. In newborns, the frequency of Gly/Arg was significantly higher in the MGH and diabetic groups than in the non-diabetic group. Taken together, groups IIA and IIB (IIA + IIB; diabetes) presented lower amounts of DNA damage than the non-diabetic group (p = 0.064). No significant association was detected between genetic damage and the presence of the Arg972 genotype in pregnant women.

Conclusion: The polymorphism was more prevalent in newborns of diabetic and MGH women. We believe that it is necessary to increase the number of subjects to be examined in order to better determine the biological role of the Arg972 polymorphism in these patients. Despite being classified as low-risk, pregnant women with mild gestational hyperglycemia characterize a population of maternal and perinatal adverse outcomes, and that, together with their newborns, require better monitoring by professionals and health services.

Keywords: DNA damage; Diabetes; Mild gestational hyperglycemia; Newborn; Polymorphism; Pregnancy.

PubMed Disclaimer

References

    1. HAPO Study Cooperative Research Group Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453–9. doi: 10.2337/db08-1112. - DOI - PMC - PubMed
    1. Rudge MVC, Calderon IMP, Ramos MD, Abbade JF, Rugolo LMSS. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10 year analysis. Gynecol Obst Invest. 2000;50:108–12. doi: 10.1159/000010293. - DOI - PubMed
    1. Negrato CA, Jovanovic L, Tambascia MA, Calderon IMP, Geloneze B, Dias A, et al. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24(4):324–30. doi: 10.1002/dmrr.815. - DOI - PubMed
    1. Silva MRG, Calderon IMP, Gonçalves LC, Aragon FF, Padovani CR, Pimenta WP. Ocorrência de diabetes melito em mulheres com hiperglicemia em gestação prévia. Rev Saude Publica. 2003;37:345–50. - PubMed
    1. Watanabe RM, Valle T, Hauser ER, Ghosh S, Eriksson J, Kohtamäki K, et al. The Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Hum Hered. 1999;49:159–68. doi: 10.1159/000022865. - DOI - PubMed

LinkOut - more resources